Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | MAP2K1 | Q02750 | 8/20 | 0.43 |
| ▸ | MAP2K2 | P36507 | 3/20 | 0.43 |
| ▸ | BRAF | P15056 | 1/20 | 0.43 |
| ▸ | MAP2K5 | Q13163 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 2/20 | 0.41 |
| ▸ | CES1 | P23141 | 2/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.39 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.39 |
| ▸ | AURKA | O14965 | 1/20 | 0.38 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.38 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6295970 | 0.89 | MAPK1 (0.47) | MAPK1MAP2K1MAP2K2BRAFMAP2K5 | |
| SCHEMBL6291256 | 0.85 | CES2 (0.45) | MAPK1MAP2K1MAP2K2BRAFMAP2K5 | |
| SCHEMBL6295965 | 0.85 | CES2 (0.47) | MAP2K1MAP2K2CES2CES1BCHE | |
| SCHEMBL4862035 | 0.85 | KAT6A (0.45) | MAPK1MAP2K1MAP2K2BRAFMAP2K5 | |
| SCHEMBL6295843 | 0.81 | CES2 (0.44) | MAP2K1MAP2K2CES2CES1BCHE | |
| SCHEMBL4851679 | 0.81 | CES2 (0.44) | MAPK1MAP2K1MAP2K2BRAFMAP2K5 | |
| SCHEMBL29941199 | 0.77 | MAP2K1 (0.52) | MAP2K1MAP2K2CES2CES1BCHE | |
| SCHEMBL27534743 | 0.77 | MAP2K1 (0.64) | MAPK1MAP2K1MAP2K2BRAFMAP2K5 | |
| SCHEMBL6291672 | 0.77 | MAP2K1 (0.50) | MAPK1MAP2K1MAP2K2BRAFMAP2K5 | |
| SCHEMBL27218132 | 0.77 | CES2 (0.55) | CES2CES1BCHEKAT6AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7411001-B2 | Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids | WARNER-LAMBERT COMPANY (US) | 2008-08-12 | — | — | US | disclosed |
| US-20050176820-A1 | Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids | WARNER-LAMBERT COMPANY | 2005-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176820-A1 | Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids | CYP4X1, CYP2A7, CYP4B1 | MAPK1 4734/4885MAP2K1 4341/4885MAP2K2 4268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.